Riva-Oxazepam: Incorrect label (Riva-Oxazepam 30MG 500 tablets DIN00568414) may be appended to affected lots that contains: Riva-Oxazepam 15MG 500 tablets DIN00568406
Last updated
Summary
Product
Riva-Oxazepam
Issue
Health products - Labelling
What to do
See instructions below.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Riva-Oxazepam |
Riva-Oxazepam 15mg 500comp |
DIN 00568406 |
Tablet |
Oxazepam 15 MG |
D0522, D0555 |
Issue
Incorrect label (Riva-Oxazepam 30MG 500 tablets DIN00568414) may be appended to affected lots that contains: Riva-Oxazepam 15MG 500 tablets DIN00568406.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers, Wholesalers
Details
Original published date: 2022-09-22
Alert / recall type
Health product recall
Category
Health product - Drugs
Companies
LABORATOIRE RIVA INC.
660 Boul. Industriel
Blainville
Quebec
Canada J7C 3V4
Published by
Health Canada
Audience
General public
Retail
Warehouse
Recall class
Type II
Identification number
RA-64575